BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human PPARα (4-96 aa) and mouse myelomacells (NS-1)
BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human HNF4α (393-461 aa) and mouse myelomacells (NS-1)
BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human NGFI-Bα (501-598 aa) and mouse myelomacells (NS-1)
BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human RARα (1-30 aa) and mouse myelomacells (NS-1)
BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human LRH-1 (161-280 aa) and mouse myelomacells (NS-1)
BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human REVERBβ (4-101 aa) and mouse myelomacells (NS-1)
BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human TRα (370-413 aa) and mouse myelomacells (NS-1)
BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human MR (2-99 aa) and mouse myelomacells (NS-1)
BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human RXRγ (2-137 aa) and mouse myelomacells (NS-1)
BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human TRβ1 (2-100 aa) and mouse myelomacells (NS-1)
BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human RORα (136-236 aa) and mouse myelomacells (NS-1)
BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human RORα (136-236 aa) and mouse myelomacells (NS-1)
BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human RARβ (2-79 aa) and mouse myelomacells (NS-1)
Produced in BALB/c mouse ascites after inoculation with hybridoma of mouse myeloma cells (NS-1) and spleen cells derived from a BALB/c mouse immunized with Baculovirus-expressed recombinant human PXR-1(1-40 aa)
BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human VDR (91-210 aa) and mouse myelomacells (NS-1)
BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human ERα (2-180 aa) and mouse myelomacells (NS-1)
BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human PR isoform B (2-99 aa) and mouse myelomacells (NS-1)
BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human RARγ (2-88 aa) and mouse myelomacells (NS-1)
BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human ERRα1 (98-171 aa) and mouse myelomacells (NS-1)
BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human RORγ (2-30 aa) and mouse myelomacells (NS-1)